Skip to content

Oxaceprol

DERMATOLOGICALS

Also known as: N-Acetyl-4-hydroxy-L-proline, N-Acetyl-4-hydroxyproline, N-Acetyl-L-hydroxyproline, N-Acetyl-trans-4-hydroxy-L-proline, N-Acetylhydroxyproline

ATC D11AX09ATC M01AX24

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Oxaceprol is a drug catalogued in DrugCentral. Recorded indications include Osteoarthritis.

  • Indications: Osteoarthritis.
  • ATC code: D11AX09 (Other dermatologicals).
  • Molecular formula: C7H11NO4; molecular weight 173.17 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Osteoarthritis

ATC classification

ATC codeTherapeutic hierarchy
D11AX09DERMATOLOGICALS › OTHER DERMATOLOGICAL PREPARATIONS › OTHER DERMATOLOGICAL PREPARATIONS › Other dermatologicals
M01AX24MUSCULO-SKELETAL SYSTEM › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS › Other antiinflammatory and antirheumatic agents, non-steroids

Chemical structure

Molecular formulaC7H11NO4
Molecular weight173.17 g/mol
CAS number33996-33-7
InChIKeyBAPRUDZDYCKSOQ-RITPCOANSA-N
PubChem CID65784
CC(=O)N1C[C@H](O)C[C@H]1C(O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Oxaceprol used for?

DrugCentral lists the following indications for Oxaceprol: Osteoarthritis.

What is the chemical formula of Oxaceprol?

Oxaceprol has the molecular formula C7H11NO4 and a molecular weight of 173.17 g/mol.

Browse: all drugs starting with O · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets0
Indications1
FormulaC7H11NO4
DrugCentral ID2005
Interactive profile